Latest News

Use of tPA for ischemic stroke nearly doubled from 2003 to 2011

Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. A research team reports both an overall increase in the use of tPA to dissolve clots blocking arteries supplying the brain and administration of the potentially life-saving drug to a more diverse group of patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Veterans generally satisfied with mental health care, study shows

  • Intervention helps smokers quit following hospital stay

  • Employee-retention practices challenged by experts

  • Recovery reversal seen in study of returning concussed athletes

  • Colds and other common infections tied to some stroke risk in kids

  • Striatum acts as hub for multisensory integration

  • Forensics research to make cadaver dogs more efficient

  • Study Identifies Challenges Faced by NYU Langone Nurses in the Aftermath of Hurricane Sandy

  • Creating pomegranate drug to stem Alzheimer's, Parkinson's

  • In our digital world, are young people losing the ability to read emotions?

  •